250 related articles for article (PubMed ID: 9950963)
21. Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats.
Opocenský M; Dvorák P; Malý J; Kramer HJ; Bäcker A; Kopkan L; Vernerová Z; Tesar V; Zima T; Bader M; Ganten D; Janda J; Vanecková I
Physiol Res; 2004; 53(6):581-93. PubMed ID: 15588125
[TBL] [Abstract][Full Text] [Related]
22. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats.
Szczepańska-Sadowska E; Paczwa P; Loń S; Ganten D
J Hypertens; 1998 Oct; 16(10):1505-14. PubMed ID: 9814623
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats.
Fontes MA; Baltatu O; Caligiorne SM; Campagnole-Santos MJ; Ganten D; Bader M; Santos RA
Physiol Genomics; 2000 Apr; 2(3):137-42. PubMed ID: 11015592
[TBL] [Abstract][Full Text] [Related]
24. Transgenic hypertensive rats show a reduced angiotensin II induced [Ca2+]i response in glomerular mesangial cells.
Tepel M; Heidenreich S; Zidek W
Life Sci; 1998; 62(1):69-76. PubMed ID: 9444969
[TBL] [Abstract][Full Text] [Related]
25. Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system.
Varcabova S; Huskova Z; Kramer HJ; Hwang SH; Hammock BD; Imig JD; Kitada K; Cervenka L
Clin Exp Pharmacol Physiol; 2013 Apr; 40(4):273-81. PubMed ID: 23039246
[TBL] [Abstract][Full Text] [Related]
26. NO-independent mechanism mediates tempol-induced renal vasodilation in SHR.
de Richelieu LT; Sorensen CM; Holstein-Rathlou NH; Salomonsson M
Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1227-34. PubMed ID: 16033921
[TBL] [Abstract][Full Text] [Related]
27. Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension.
Patterson ME; Mouton CR; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F754-9. PubMed ID: 15900020
[TBL] [Abstract][Full Text] [Related]
28. Effects of long-term intrarenal angiotensin II infusion on renal vascular responsiveness to vasoactive agents.
Fitzgerald SM; Stevenson KM; Evans RG; Anderson WP
Clin Exp Pharmacol Physiol; 1998; 25(7-8):633-6. PubMed ID: 9673443
[TBL] [Abstract][Full Text] [Related]
29. Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats.
Vanecková I; Skaroupková P; Dvorák P; Certíková Chábová V; Tesar V; Bader M; Ganten D; Kramer HJ
Physiol Res; 2005; 54(1):17-24. PubMed ID: 15717837
[TBL] [Abstract][Full Text] [Related]
30. Exaggerated natriuresis in transgenic (mRen2)27 rats.
Schneider K; Gross V; Lippoldt A; Luft FC
J Hypertens; 1997 Sep; 15(9):1041-8. PubMed ID: 9321753
[TBL] [Abstract][Full Text] [Related]
31. Endothelial vasoconstrictor prostanoids modulate contractions to acetylcholine and ANG II in Ren-2 rats.
Noll G; Lang MG; Tschudi MR; Ganten D; Lüscher TF
Am J Physiol; 1997 Jan; 272(1 Pt 2):H493-500. PubMed ID: 9038972
[TBL] [Abstract][Full Text] [Related]
32. Circadian rhythms in renal function in hypertensive TGR(mRen-2)27 rats and their normotensive controls.
Pons M; Schnecko A; Witte K; Lemmer B; Waterhouse JM; Cambar J
Am J Physiol; 1996 Oct; 271(4 Pt 2):R1002-8. PubMed ID: 8897993
[TBL] [Abstract][Full Text] [Related]
33. Cholesterol feeding does not alter renal hemodynamic response to acetylcholine and angiotensin II in rabbits.
Carroll JF; Mizelle HL; Cockrell K; Reckelhoff JF; Clower BR; Granger JP
Am J Physiol; 1997 Mar; 272(3 Pt 2):R940-7. PubMed ID: 9087658
[TBL] [Abstract][Full Text] [Related]
34. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
Handa RK; Strandhoy JW; Handa SE
Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
[TBL] [Abstract][Full Text] [Related]
35. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
Tokita Y; Franco-Saenz R; Mulrow PJ
Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
[TBL] [Abstract][Full Text] [Related]
36. Enalapril and pressure-diuresis in hypertensive rats transgenic for mouse renin gene.
Springate J; Van Liew J; Ganten D
Kidney Blood Press Res; 1997; 20(1):1-5. PubMed ID: 9192903
[TBL] [Abstract][Full Text] [Related]
37. Interactions between renal vascular resistance and endothelium-derived hyperpolarization in hypertensive rats in vivo.
Stannov SU; Brasen JC; Salomonsson M; Holstein-Rathlou NH; Sorensen CM
Physiol Rep; 2019 Aug; 7(15):e14168. PubMed ID: 31368238
[TBL] [Abstract][Full Text] [Related]
38. Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats.
Chatziantoniou C; Arendshorst WJ
Am J Physiol; 1992 Oct; 263(4 Pt 2):F573-80. PubMed ID: 1329556
[TBL] [Abstract][Full Text] [Related]
39. Progression of renal failure after subtotal nephrectomy in transgenic rats carrying an additional renin gene [TGR(mREN2)27].
Wagner J; Klotz S; Haufe CC; Danser JA; Amann K; Ganten D; Ritz E
J Hypertens; 1997 Apr; 15(4):441-9. PubMed ID: 9211179
[TBL] [Abstract][Full Text] [Related]
40. Enhanced tubuloglomerular feedback in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Mitchell KD; Mullins JJ
Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1210-6. PubMed ID: 16033920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
